WHO GMP gap identified during remediation planning – avoiding repeat WHO observations



Published on 28/01/2026

Addressing WHO GMP Gaps During Remediation Planning to Prevent Recurrence

In today’s regulatory landscape, pharmaceutical manufacturers face increasing scrutiny from global health authorities. Observations from the World Health Organization (WHO) regarding Good Manufacturing Practices (GMP) can have significant implications for a company’s operational credibility and market access. This article provides a comprehensive playbook for identifying and remediating WHO GMP gaps effectively, thereby helping professionals in GMP compliance and audit readiness.

By implementing the actionable steps outlined in this playbook, readers will be equipped to respond swiftly to inspection findings, conduct deep-dive analyses of compliance issues, and establish robust controls. The outcome is a systematic approach to ongoing quality assurance, positioning your organization for inspection readiness and continuous compliance with regulatory standards.

Symptoms/Signals on the Floor or in the Lab

Identifying symptoms or signals indicating a potential gap in WHO GMP compliance involves keen observation and the right monitoring tools. Here are some common red flags that may be indicative of underlying issues:

  • Frequent Deviations: An
uptick in deviation reports or out-of-specification results can signal systemic problems in quality controls.
  • Increased Complaints: Spike in product complaints may reflect potential deficiencies in manufacturing quality or product consistency.
  • Non-Conformance Trends: Regular patterns in non-conformance reports point to deficiencies in the quality management system (QMS).
  • Employee Feedback: Insights from production and quality control staff can reveal unreported problems or concerns about standard operating procedures (SOPs).
  • Inspection Findings: Comments or observations from previous inspections highlight critical areas that need immediate action.
  • Likely Causes

    Understanding the root causes of identified symptoms is essential for effective remediation. Causes can be categorized into several domains:

    Materials

    – Poor quality of raw materials leading to inconsistencies in manufactured products.
    – Inadequate vendor qualification processes resulting in unverified suppliers.

    Method

    – Unclear or outdated manufacturing procedures that are not aligned with current best practices.
    – Insufficient training of personnel in new or modified procedures.

    Machine

    – Equipment not maintained according to GMP standards, leading to failures or inaccuracies in production.
    – Lack of proper calibration or validation of instruments.

    Man

    – Inadequate training and competency assessments for staff involved in critical processes.
    – High turnover rates leading to a loss of institutional knowledge.

    Measurement

    – Inaccurate measurement tools or methods that compromise data reliability.
    – Lack of ongoing verification of analytical methodologies.

    Environment

    – Inadequate control of the manufacturing environment, such as temperature and humidity.
    – Issues in maintaining cleanroom standards leading to contaminations.

    Immediate Containment Actions (first 60 minutes)

    When a gap has been identified, immediate containment actions are critical. These should occur within the first hour of detection:

    1. **Cease Production:** Immediately halt any suspect operations to prevent further production of potentially non-compliant products.
    2. **Document the Incident:** Create an initial report detailing observations, people involved, and potential affected batches or materials.
    3. **Notify Key Stakeholders:** Alert quality assurance, production management, and regulatory affairs teams of the situation for a collaborative containment effort.
    4. **Isolate Affected Materials:** Segregate any batches, raw materials, or equipment linked to the identified gap.
    5. **Implement Preliminary Controls:** Put in place temporary process controls to prevent recurrence while a full investigation is underway.

    Investigation Workflow

    Following immediate containment, a systematic investigation is necessary. This involves collecting specific data and interpreting it within the context of the deviation:

    1. **Gather Documentation:** Collect batch records, reports, and logs that pertain to the issue. Relevant documents include:
    – Batch production records
    – Equipment maintenance records
    – SOPs and training records

    2. **Interview Personnel:** Conduct interviews with operators, quality control analysts, and managers to obtain first-hand accounts of the situation.

    3. **Data Analysis:**
    – Compare data from affected processes against historical data to identify anomalies.
    – Review trends from previous deviations for correlations.

    Root Cause Tools

    Effective root cause analysis (RCA) requires the application of structured methodologies. Here are three common tools:

    5-Why Analysis

    – **When to use:** This method is particularly useful for straightforward problems where the cause can be traced to operational failures.
    – **Example:** Asking “Why?” five times to drill down to the underlying issue.

    Fishbone Diagram (Ishikawa)

    – **When to use:** Best applied when the team needs to brainstorm various potential causes in different categories.
    – **Example:** A visual tool mapping causes to symptoms across categories of materials, methods, machines, and other areas.

    Fault Tree Analysis (FTA)

    – **When to use:** Effective for complex problems requiring a systematic breakdown of potential failure pathways.
    – **Example:** Creating a tree that graphically represents combinations of failures leading to non-compliance.

    CAPA Strategy

    Once root causes are identified, it’s vital to develop a Corrective and Preventive Action (CAPA) strategy:

    Correction

    – Immediate actions taken to rectify the identified issue, such as reprocessing or disposal of affected products.

    Corrective Action

    – Long-term actions aimed to address root causes effectively. For instance, updating training programs, revising SOPs, or enhancing supplier quality assurance.

    Preventive Action

    – Strategies implemented to ensure the issue does not recur. Examples include regular audits, employee retraining, and improvements in manufacturing processes and equipment.

    Control Strategy & Monitoring

    A robust, sustainable control strategy is crucial for ensuring ongoing compliance:

    1. **Statistical Process Control (SPC):** Employ SPC to monitor and analyze processes. Use control charts to visualize process variations in real-time.
    2. **Regular Sampling and Testing:** Establish a sampling plan proportional to production volume, frequency, and historical performance data to ensure consistent quality verification.
    3. **Alarms and Alerts:** Implement systems that signal deviations from established parameters, providing timely intervention opportunities.
    4. **Verification and Reviews:** Schedule regular assessments of critical processes for performance and compliance checks.

    Validation / Re-qualification / Change Control Impact

    In addressing WHO GMP gaps, organizations may often need to revisit validation and change control protocols:

    1. **Validation Assessments:** Evaluate whether validation protocols for affected processes and equipment require re-examination or re-qualification.

    2. **Change Control Procedures:** Assess if any changes were implemented pre-issue that could have led to the gap. Ensure changes are documented through established change control procedures.

    3. **Documentation Requirements:** Maintain complete and thorough documentation during these processes to support compliance claims during inspections.

    Inspection Readiness: What Evidence to Show

    For regulatory inspections, companies must be prepared with comprehensive evidence demonstrating compliance:

    – **Records of Deviations:** Maintain an organized log of all deviation reports and subsequent actions taken.
    – **Training Logs:** Up-to-date records confirming employee training and competency evaluations.
    – **Batch Documentation:** Ensure batch production records for affected batches are readily accessible and complete.
    – **Corrective Action Records:** Document all CAPA activities, demonstrating a thorough approach to resolving the root causes of identified gaps.

    FAQs

    What types of gaps can be identified in WHO GMP compliance?

    Gaps can range from inadequate documentation practices to environmental controls, employee training, and equipment qualifications.

    How quickly should containment actions be initiated after a gap is identified?

    Containment actions should be initiated within the first hour of identification to minimize potential impacts.

    What is the significance of root cause analyses in regulatory compliance?

    RCA is critical for identifying true sources of issues, enabling targeted corrective and preventive actions to prevent recurrence.

    What are effective methods for training employees on GMP compliance?

    Utilizing hands-on training, refresher courses, and continuous performance assessments can foster a culture of compliance.

    How often should control strategies be reviewed?

    Control strategies should be reviewed regularly, ideally quarterly or after any significant process changes.

    What role does documentation play in ensuring inspection readiness?

    Thorough documentation provides a clear audit trail to demonstrate compliance and the effectiveness of CAPA efforts during inspections.

    Can suppliers impact GMP compliance?

    Yes, supplier quality directly affects product quality; hence, rigorous supplier qualification and evaluation protocols are necessary.

    What steps should be taken in case a gap reoccurs despite previous remediation efforts?

    Reassess the CAPA strategy, conduct a new root cause analysis, and review all relevant processes and training to identify new contributing factors.


    Related Reads

    Pharma Tip:  Documentation not aligned to WHO during remediation planning – gap remediation roadmap